ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,856,506 | -9.0% | 10,274,141 | +3.1% | 0.00% | 0.0% |
| Q2 2023 | $22,929,913 | -10.6% | 9,969,527 | +17.8% | 0.00% | 0.0% |
| Q1 2023 | $25,646,179 | +26.5% | 8,464,086 | -2.7% | 0.00% | 0.0% |
| Q4 2022 | $20,271,914 | +42.1% | 8,700,392 | +16.5% | 0.00% | – |
| Q3 2022 | $14,264,000 | -30.2% | 7,467,818 | -1.0% | 0.00% | -100.0% |
| Q2 2022 | $20,433,000 | +0.5% | 7,540,382 | +10.5% | 0.00% | 0.0% |
| Q1 2022 | $20,338,000 | -15.2% | 6,824,829 | +10.7% | 0.00% | 0.0% |
| Q4 2021 | $23,986,000 | -5.8% | 6,166,349 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $25,463,000 | +44.0% | 5,935,203 | +1.7% | 0.00% | – |
| Q2 2021 | $17,682,000 | +153.1% | 5,835,573 | +178.2% | 0.00% | – |
| Q1 2021 | $6,985,000 | +8.0% | 2,097,710 | +15.2% | 0.00% | – |
| Q4 2020 | $6,465,000 | +97.5% | 1,821,107 | +74.2% | 0.00% | – |
| Q3 2020 | $3,273,000 | +739.2% | 1,045,394 | +387.9% | 0.00% | – |
| Q2 2020 | $390,000 | +271.4% | 214,276 | +106.7% | 0.00% | – |
| Q1 2020 | $105,000 | -61.7% | 103,671 | +5.2% | 0.00% | – |
| Q4 2019 | $274,000 | -73.1% | 98,537 | -85.3% | 0.00% | – |
| Q3 2019 | $1,019,000 | -25.6% | 668,556 | +1.6% | 0.00% | – |
| Q2 2019 | $1,369,000 | -83.5% | 658,289 | -71.5% | 0.00% | – |
| Q1 2019 | $8,278,000 | -10.9% | 2,312,132 | -4.6% | 0.00% | – |
| Q4 2018 | $9,286,000 | -59.4% | 2,424,682 | +0.1% | 0.00% | -100.0% |
| Q3 2018 | $22,891,000 | +31.1% | 2,422,221 | +1.3% | 0.00% | 0.0% |
| Q2 2018 | $17,455,000 | +405.9% | 2,391,143 | +246.6% | 0.00% | – |
| Q1 2018 | $3,450,000 | -9.1% | 689,906 | -8.2% | 0.00% | – |
| Q4 2017 | $3,794,000 | +6223.3% | 751,314 | +7615.3% | 0.00% | – |
| Q3 2017 | $60,000 | – | 9,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |